Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TSXV/IBO stock hub

TSXV/IBO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSXV/IBOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.6M

TSX Venture Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSXV/IBO

In the news

Latest news · TSXV/IBO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-161.4

P25 -121.5P50 -40.9P75 0.5

ROIC-12.3

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSXV/IBO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

154

Groups with data

Currency

CAD

Showing 154 of 154 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 4M
Exchange	TSX Venture Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA91360F1099
Last refreshed	2026-05-10
Market cap	CAD 1.6M
Price	CAD 0.01
Price currency	CAD
Sector	Healthcare
Sic	8063
Symbol	tsxv/IBO
Website	https://universalibogaine.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-94.38%
EV Earnings	-2.71x
EV/FCF	-6.04x
EV/Sales	1.95x
FCF yield	-42.42%
P/B ratio	5.75x
P/S ratio	0.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-34.25%
EBITDA Margin	-17.39%
Gross margin	17.31%
Gross Profit	CAD 356,649
Gross Profit Growth	-45.95%
Gross Profit Growth Q	191.01%
Gross Profit Growth3 Y	-12.96%
Net Income	CAD -1.5M
Net Income Growth Quarters	5%
Pretax Margin	-71.66%
Profit Margin	-71.66%
ROA	-9.46
Roa5y	-61
ROCE	-35.38
ROE	-161.4
Roe5y	-298.3
ROIC	-12.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-75.02%
Cagr3y	-37%
EPS Growth Quarters	5
Revenue Growth	-11.68x
Revenue Growth Q	30.61x
Revenue Growth3 Y	29.92x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.44
Assets	CAD 4M
Cash	CAD 127,746
Current Assets	CAD 783,819
Current Liabilities	CAD 2M
Debt	CAD 2.6M
Debt Equity	CAD 9.45
Debt FCF	CAD -3.88
Equity	CAD 272,174
Interest Coverage	-4.6
Liabilities	CAD 3.7M
Long Term Assets	CAD 3.2M
Long Term Liabilities	CAD 1.7M
Net Cash	CAD -2.4M
Net Cash By Market Cap	CAD -156
Net Debt Equity	CAD 8.98
Tangible Book Value	CAD 272,174
Tangible Book Value Per Share	CAD 0
WACC	13.67

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.39
Net Working Capital	CAD -507,013
Quick ratio	0.37
Working Capital	CAD -1.2M
Working Capital Turnover	CAD -2.54

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-38.51%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-75%
200-day SMA	0.02
3Y total return	-75%
50-day SMA	0.01
50-day SMA vs 200-day SMA	50under200
All Time High	0.25
All Time High Change	-98%
All Time High Date	2021-11-03
All Time Low	0.01
All Time Low Change	0%
All Time Low Date	2023-09-20
ATR	0
Beta	4.39
Beta1y	-0.61
Beta2y	-1.23
High	0.01
High52	0.05
High52 Date	2025-07-02
High52ch	-88.89%
Low	0.01
Low52	0.01
Low52 Date	2026-02-02
Low52ch	0%
Ma50ch	-34.21%
Price vs 200-day SMA	-70.76%
RSI	42.68
RSI Monthly	38.84
RSI Weekly	40.48
Sharpe ratio	2.08x
Sortino ratio	4.36
Total Return	-38.51%
Tr1w	-50%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -705,732
Operating margin	-34.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	307,310,516%
Net Borrowing	-218,473
Shares Insiders	1.77%
Shares Out	312,858,516
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -730,571
Average Volume	241,304.4x
Bv Per Share	0
CAPEX	CAD -20,695
Ch1w	-50
Ch1y	-75
Ch3y	-75
Ch6m	-80
Change	-50%
Change From Open	0
Close	0.01
Days Gap	0
Depreciation Amortization	347,451
Dollar Volume	8,300.8
Earnings Date	2026-03-27
EBIT	CAD -705,732
EBITDA	CAD -358,281
EPS	CAD -0.01
F Score	3
FCF	CAD -663,497
FCF EV Yield	-16.55x
FCF Per Share	CAD -0
Financing CF	321,129
Fiscal Year End	July
Investing CF	-20,695
Is Primary Listing	1
Last Earnings Date	2025-11-28
Last Report Date	2025-04-30
Ma150	0.02
Ma150ch	-67.74%
Ma20	0.01
Ma20ch	-35.9%
Net CF	-342,368
Open	0.01
Ppne	3,222,869
Price Date	2026-02-02
Ptbv Ratio	5.75
Relative Volume	6.88x
Revenue	2,060,280x
SBC By Revenue	3.26x
Share Based Comp	67,074
Tr6m	-80%
Volume	1,660,150
Z Score	-9.42

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSXV/IBO pay a dividend?

Capital-return profile for this ticker.

Performance

TSXV/IBO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSXV/IBO?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+1.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

TSXV/IBO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.7

Neutral momentum band

Price vs 200-day MA

-70.8%

50/200-day relationship not available

Beta (5Y)

4.39

More volatile than the market

Sharpe ratio

2.08

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSXV/IBO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsxv/IBO stock rating?

tsxv/IBO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsxv/IBO analysis?

The full report lives at /stocks/tsxv/IBO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsxv/IBO?

The latest report frames tsxv/IBO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsxv/IBO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.